Strategies to improve the medical device life cycle in Mexico
Objective. To analyze the role of stakeholders to three alternative strategies to improve processes and practices regarding the regulation, assessment, and management oforthopaedic medical devices in Mexico. Materials and methods. The study was based on document analysis and 17 structured interviews...
Saved in:
Main Authors: | Myriam Lingg (Author), Anahi Dreser (Author), Luis Durán-Arenas (Author), Kaspar Wyss (Author) |
---|---|
Format: | Book |
Published: |
Instituto Nacional de Salud Pública,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hacia una política farmacéutica integral para México
by: René Leyva, et al.
Published: (2006) -
Challenges and opportunities for the development of a national pharmaceutical policy in México
by: Veronika J Wirtz, et al.
Published: (2013) -
Uso de antibióticos en México: revisión de problemas y políticas Antibiotic use in Mexico: review of problems and policies
by: Anahí Dreser, et al.
Published: (2008) -
How to calculate the life cycle of high-risk medical devices for patient safety
by: Gihong Seo, et al.
Published: (2022) -
Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation
by: Dreser Anahí, et al.
Published: (2012)